Latest Production News

Sparc Technologies has secured a fourth trial agreement with BHP Mitsubishi Alliance to test its graphene-enhanced ecosparc® coating in harsh mining conditions, aiming to validate its anti-corrosive performance against market leaders.

New World Resources has secured a critical federal permitting milestone for its Antler Copper Project, setting a clear path to full approval within 12 months and construction commencement in H2 2025.

Tamboran Resources has achieved a significant operational milestone in the Beetaloo Basin, delivering record-breaking stimulation efficiency in its SS-2H ST1 well. The company now advances towards flow back and extended production testing, signaling potential for enhanced gas output.

Domino's Pizza Enterprises signals a strategic reset with the closure of 205 underperforming stores, primarily in Japan, aiming to sharpen focus and improve profitability while maintaining steady earnings guidance.

Tempest Minerals has signed a Memorandum of Understanding with Green Steel and Iron to develop a $3 billion hot briquette iron processing hub near its Yalgoo Project, aiming to supply high-grade magnetite for green steelmaking.

Nick Scali Limited reported a robust 1H FY25 with revenue growth and profits exceeding guidance, despite ongoing UK market disruptions and restructuring costs.

Nick Scali Limited reported a stronger-than-expected half-year profit, driven by solid ANZ performance, while its UK operations continue to face restructuring challenges amid store refurbishments.

Nick Scali Limited’s half-year results reveal a 30.2% decline in statutory profit, impacted by UK acquisition losses and restructuring costs, yet the company maintains shareholder returns with a fully franked interim dividend.

Neuren Pharmaceuticals has secured a pivotal FDA Type C Meeting to discuss primary efficacy endpoints for its Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, advancing its rare disease drug development.

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.

Northern Minerals has completed the second tranche of its placement, raising $41.5 million to advance its Browns Range Heavy Rare Earth Project, focusing on the high-grade Wolverine deposit.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.